United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market (2025-2031) | Industry, Forecast, Trends, Segmentation, Analysis, Value, Growth, Size & Revenue, Competitive Landscape, Companies, Share, Outlook

Market Forecast By Cancer Type (Lung Adenocarcinoma (LUAD), Lung Squamous Cell carcinoma (LUSC), Large Cell Carcinoma, Others), By Product (Reagents & Kits, Instruments And Services & Softwares), By Test (Imaging Test, Molecular Test, Biopsy, Sputum Cytology, Thoracentesis, Immunohistochemistry, Others), By End-User (Hospital, Clinical Laboratories, Academics, Others) And Competitive Landscape
Product Code: ETC9949969 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Shubham Padhi No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Outlook
  • Market Size of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market, 2024
  • Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market, 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Revenues & Volume for the Period 2021- 2031
  • United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Trend Evolution
  • United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Drivers and Challenges
  • United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Price Trends
  • United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Porter's Five Forces
  • United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Industry Life Cycle
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Cancer Type for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Lung Adenocarcinoma (LUAD) for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Lung Squamous Cell carcinoma (LUSC) for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Large Cell Carcinoma for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Product for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Reagents & Kits for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Instruments And Services & Softwares for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Test for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Imaging Test for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Molecular Test for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Biopsy for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Sputum Cytology for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Thoracentesis for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Immunohistochemistry for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By End-User for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Hospital for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Clinical Laboratories for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Academics for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume By Others for the Period 2021- 2031
  • United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Import Export Trade Statistics
  • Market Opportunity Assessment By Cancer Type
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By Test
  • Market Opportunity Assessment By End-User
  • United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Top Companies Market Share
  • United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Competitive Benchmarking By Technical and Operational Parameters
  • United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Company Profiles
  • United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Overview

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market - Industry Life Cycle

3.4 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market - Porter's Five Forces

3.5 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F

3.6 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F

3.7 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Test, 2021 & 2031F

3.8 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By End-User, 2021 & 2031F

4 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing incidence of non-small cell lung cancer in the UK

4.2.2 Advancements in diagnostic technologies for non-small cell lung cancer

4.2.3 Growing awareness and early detection initiatives for lung cancer in the UK

4.3 Market Restraints

4.3.1 High cost associated with advanced diagnostic tests and treatments

4.3.2 Limited access to specialized diagnostic centers in certain regions of the UK

4.3.3 Stringent regulatory requirements for approval of diagnostic tests in the UK

5 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Trends

6 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market, By Types

6.1 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market, By Cancer Type

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Cancer Type, 2021- 2031F

6.1.3 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Lung Adenocarcinoma (LUAD), 2021- 2031F

6.1.4 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Lung Squamous Cell carcinoma (LUSC), 2021- 2031F

6.1.5 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Large Cell Carcinoma, 2021- 2031F

6.1.6 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

6.2 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market, By Product

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Reagents & Kits, 2021- 2031F

6.2.3 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Instruments And Services & Softwares, 2021- 2031F

6.3 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market, By Test

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Imaging Test, 2021- 2031F

6.3.3 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Molecular Test, 2021- 2031F

6.3.4 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Biopsy, 2021- 2031F

6.3.5 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Sputum Cytology, 2021- 2031F

6.3.6 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Thoracentesis, 2021- 2031F

6.3.7 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F

6.4 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market, By End-User

6.4.1 Overview and Analysis

6.4.2 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Hospital, 2021- 2031F

6.4.3 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Clinical Laboratories, 2021- 2031F

6.4.4 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Academics, 2021- 2031F

6.4.5 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

7 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Import-Export Trade Statistics

7.1 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Export to Major Countries

7.2 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Imports from Major Countries

8 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Key Performance Indicators

8.1 Average time from initial symptoms to diagnosis for non-small cell lung cancer patients in the UK

8.2 Number of new diagnostic technologies adopted in the UK non-small cell lung cancer diagnostics market

8.3 Percentage increase in early-stage diagnosis rates for non-small cell lung cancer in the UK

9 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market - Opportunity Assessment

9.1 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F

9.2 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F

9.3 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Test, 2021 & 2031F

9.4 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By End-User, 2021 & 2031F

10 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market - Competitive Landscape

10.1 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Non-Small Cell Lung Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All